Partner news
News
Partner news
BioMed X Institute starts new project in immunology research with Janssen
Read full storyPartner news
Alderley Park launches breakthrough Oncology Development Programme in collaboration with Cancer Research UK, Innovate UK, Medicines Discovery Catapult and global pharma and healthcare companies
Read full storyPartner news
Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator, SDI-118, in development for the treatment of cognitive impairment.
Read full storyPartner news
Vifor Pharma enters into commercial collaboration in the US with Janssen
Read full storyPartner news
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
Read full storyPartner news
Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders
Read full storyPartner news
On Target Laboratories secures $40 million financing led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC)
Read full storyPartner news
ReVision Optics Raises $32 Million to Fund Expansion of U.S. Commercialization of Raindrop® Near Vision Inlay
Read full storyPartner news
Inivata and N-of-One Partner to Provide Personalized Genomic Interpretation and Clinical Trial Matching for Cancer Patients
Read full storyPartner news
Biosense Webster, Inc. Announces Acquisition of Coherex Medical, Inc.
Read full storyPartner news
First Aid Shot Therapy Rakes in $24 MM Series C
Read full storyPartner news
La Lumiere Closes $20 Million Series B Financing
Read full storyPartner news
Four Health Care IPOs: Nevro
Read full storyPartner news